Grantham, Mayo, Van Otterloo & Co (GMO)
CNMD icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s CONMED CNMD Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-71,600
Closed -$4.1M – 764
2020
Q1 		$4.1M Buy
+71,600
New +$6.6M 0.03% 271
2019
Q3 		– Sell
-10,500
Closed -$898K – 737
2019
Q2 		$898K Buy
+10,500
New +$863K 0.01% 539
2019
Q1 		– Sell
-5,500
Closed -$353K – 705
2018
Q4 		$353K Hold
5,500
– – ﹤0.01% 471
2018
Q3 		$436K Buy
+5,500
New +$425K ﹤0.01% 452

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return